Pursuing breakthroughs that will change how cancer is treated forever
Cancer is a complex disease with hundreds of variations and an ability to adapt and evolve. It’s critical that we fund the development of groundbreaking clinical trials that The Royal Marsden can rapidly translate into improved outcomes, quicker recovery times and a better quality of life for its patients.
Pioneering research is absolutely critical to extending, improving and saving the lives of more people diagnosed with cancer. That’s why we’re dedicated to helping run life-saving clinical trials that give patients at the hospital, across the UK and around the world access to the latest breakthrough drugs.
How we are funding research
Within our £15 million five-year research grant, we are funding a consultant in early cancer diagnosis, dedicated to ensuring more lives are saved by diagnosing cancer sooner.
Thanks to our supporters, including a generous grant from Oak Foundation, we continue to support The Royal Marsden’s Oak Paediatric and Adolescent Drug Development Unit (OPDDU). The OPDDU improves cancer survival rates in children by driving forward drug development and giving these young patients access to the latest innovative treatments.
Support our work
We can only continue to do this groundbreaking research with the generous donations from our supporters. Help us to support more live-saving research.
We deliver new clinical trials to patients across all tumour types. What drives us is the sense of hope the unit brings. Our patients come from across the country to enter clinical trials, and the fact that we can give them that chance is what sets us apart.